216 related articles for article (PubMed ID: 36696881)
1. Albumin-myosteatosis gauge as a novel prognostic risk factor in patients with non-metastatic colorectal cancer.
Kim Y; Lee JH; Cho ES; Lee HS; Shin SJ; Park EJ; Baik SH; Lee KY; Kang J
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):860-868. PubMed ID: 36696881
[TBL] [Abstract][Full Text] [Related]
2. Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy.
Sahin TK; Ozbay Y; Altunbulak AY; Altunbulak HI; Onur MR; Ceylan F; Guven DC; Yalcin S; Dizdar O
Int J Clin Oncol; 2024 Jun; 29(6):822-831. PubMed ID: 38565751
[TBL] [Abstract][Full Text] [Related]
3. Skeletal muscle gauge as a prognostic factor in patients with colorectal cancer.
Park IK; Yang SS; Chung E; Cho ES; Lee HS; Shin SJ; Im YC; Park EJ; Baik SH; Lee KY; Kang J
Cancer Med; 2021 Dec; 10(23):8451-8461. PubMed ID: 34643052
[TBL] [Abstract][Full Text] [Related]
4. Association of Albumin-Bilirubin Grade and Myosteatosis with its Prognostic Significance for Patients with Colorectal Cancer.
Koh HH; Cho ES; Lee JH; Shin SJ; Lee HS; Park EJ; Baik SH; Lee KY; Kang J
Ann Surg Oncol; 2022 Jun; 29(6):3868-3876. PubMed ID: 35211856
[TBL] [Abstract][Full Text] [Related]
5. Different computed tomography parameters for defining myosteatosis in patients with advanced non-small cell lung cancer.
Zhang W; Tang J; Tang H; Xie L; Wang J; Wu J; Yang M
Clin Nutr; 2023 Dec; 42(12):2414-2421. PubMed ID: 37871482
[TBL] [Abstract][Full Text] [Related]
6. Combined impact of myosteatosis and liver steatosis on prognosis in stage I-III colorectal cancer patients.
Lee DH; Jo I; Lee HS; Kang J
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2908-2915. PubMed ID: 37964719
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of muscle measurement using the standardized phase of computed tomography in patients with advanced ovarian cancer.
Huang CY; Sun FJ; Lee J
Nutrition; 2020 Apr; 72():110642. PubMed ID: 31986319
[TBL] [Abstract][Full Text] [Related]
9. Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer.
Lee J; Lin JB; Wu MH; Jan YT; Chang CL; Huang CY; Sun FJ; Chen YJ
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):814-826. PubMed ID: 31094101
[TBL] [Abstract][Full Text] [Related]
10. Varying clinical relevance of sarcopenia and myosteatosis according to age among patients with postoperative colorectal cancer.
Cho HJ; Lee HS; Kang J
J Nutr Health Aging; 2024 Apr; 28(7):100243. PubMed ID: 38643603
[TBL] [Abstract][Full Text] [Related]
11. Deep learning-based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment.
Nowak S; Kloth C; Theis M; Marinova M; Attenberger UI; Sprinkart AM; Luetkens JA
Eur Radiol; 2024 Jan; 34(1):279-286. PubMed ID: 37572195
[TBL] [Abstract][Full Text] [Related]
12. The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer.
Dolan RD; Almasaudi AS; Dieu LB; Horgan PG; McSorley ST; McMillan DC
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):111-122. PubMed ID: 30460764
[TBL] [Abstract][Full Text] [Related]
13. Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.
Findlay M; White K; Brown C; Bauer JD
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2187-2198. PubMed ID: 34676673
[TBL] [Abstract][Full Text] [Related]
14. Muscle radiodensity and mortality in patients with colorectal cancer.
Kroenke CH; Prado CM; Meyerhardt JA; Weltzien EK; Xiao J; Cespedes Feliciano EM; Caan BJ
Cancer; 2018 Jul; 124(14):3008-3015. PubMed ID: 29797673
[TBL] [Abstract][Full Text] [Related]
15. SARC-F as a screening tool to detect computed tomography-based sarcopenia and myosteatosis among older adults with cancer.
Hess DL; Harmon C; Bhatia S; Williams GR; Giri S
Cancer Med; 2023 Nov; 12(22):20690-20698. PubMed ID: 37916460
[TBL] [Abstract][Full Text] [Related]
16. Association of malignant ascites with systemic inflammation and muscle loss after treatment in advanced-stage ovarian cancer.
Weng CS; Huang WC; Chang CL; Jan YT; Chen TC; Lee J
J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):2114-2125. PubMed ID: 37503876
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
Martin L; Hopkins J; Malietzis G; Jenkins JT; Sawyer MB; Brisebois R; MacLean A; Nelson G; Gramlich L; Baracos VE
Ann Surg Oncol; 2018 Sep; 25(9):2669-2680. PubMed ID: 30006691
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy.
Tang R; Deng JP; Zhang L; Zhang WW; Sun JY; Chi F; Zhang J; Wu SG; He ZY
BMC Cancer; 2022 Mar; 22(1):234. PubMed ID: 35241010
[TBL] [Abstract][Full Text] [Related]
19. Impact of low skeletal muscle mass and quality on clinical outcomes in patients with head and neck cancer undergoing (chemo)radiation.
Bardoscia L; Besutti G; Pellegrini M; Pagano M; Bonelli C; Bonelli E; Braglia L; Cozzi S; Roncali M; Iotti C; Pinto C; Pattacini P; Ciammella P
Front Nutr; 2022; 9():994499. PubMed ID: 36466387
[TBL] [Abstract][Full Text] [Related]
20. Skeletal muscle is prognostic in resected stage III malignant melanoma.
Youn S; Eurich DT; McCall M; Walker J; Smylie M; Sawyer MB
Clin Nutr; 2022 May; 41(5):1066-1072. PubMed ID: 35397311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
